Concepedia
Statistics
Publications
24
Citations
754
H-Index
18
Active since
2012
Affiliations
Weifang Medical University(Current)
Bioscience (China)
Weifang University of Science and Technology
Weifang People's Hospital
Weifang University
Jingliang Wu is an author at Weifang Medical University specializing in nanomedicine, engineering, and medicine.
Top concepts
NanomedicineMedicineEngineeringBiomedical EngineeringPharmacologyDrug DeliveryRadiation OncologyNanoparticlesMatrix BiologyExtracellular Matrix
Publications per year
2012–2024
Co-Delivery of Curcumin and Capsaicin by Dual-Targeting Liposomes for Inhibition of aHSC-Induced Drug Resistance and Metastasis
Cuiping Qi, Di Wang, Xue Gong et al. · ACS Applied Materials & Interfaces · 2021 · 73 citations
Improved efficacy of doxorubicin delivery by a novel dual-ligand-modified liposome in hepatocellular carcinoma
Xiaocheng Li, Wenbin Diao, Hantao Xue et al. · Cancer Letters · 2020 · 63 citations
Nanomedicine, Novel Dual-ligand-modified Liposome, Hepatocellular Carcinoma +11
Combined anti-hepatocellular carcinoma therapy inhibit drug-resistance and metastasis via targeting “substance P-hepatic stellate cells-hepatocellular carcinoma” axis
Zhipeng Li, Fangqing Wang, Yanying Li et al. · Biomaterials · 2021 · 58 citations · Full text
<p>Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects</p>
Hong Jiang, Zhipeng Li, Guixiang Tian et al. · International Journal of Nanomedicine · 2019 · 53 citations · Full text
Liver-Targeted Combination Therapy Basing on Glycyrrhizic Acid-Modified DSPE-PEG-PEI Nanoparticles for Co-delivery of Doxorubicin and Bcl-2 siRNA
Guixiang Tian, Ruiyan Pan, Bo Zhang et al. · Frontiers in Pharmacology · 2019 · 46 citations · Full text
1–5 of 24